Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Long-term treatment with Fosrenol controls phosphate in end-stage renal disease

April 11, 2003

New series of PDE5 inhibitors in early development at Schering-Plough

April 11, 2003

Novel 5alpha-reductase inhibitors covered by Jenapharm patent

April 11, 2003

DA-8159 is well tolerated in healthy volunteers and without significant hemodynamic effects

April 8, 2003

Renagel receives NHI drug price listing in Japan

April 8, 2003

Sumitomo presents new muscarinic M3 antagonists for use in urinary incontinence

April 7, 2003

ACS news: inhibitors of phosphate transport for use in patients with chronic renal disease

April 2, 2003

Oxytocin agonists with utility in erectile dysfunction claimed by Ferring

April 1, 2003

BioXell commences phase II trial of BXL-628

March 31, 2003

Bayer presents novel VR1 antagonists for urinary incontinence, pain, etc.

March 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...